
In the first quarter, Novo Nordisk's sales amounted to DKK 78.09 billion, estimated at DKK 78.7 billion

Novo Nordisk's first-quarter sales reached DKK 78.09 billion, estimated at DKK 78.7 billion. Risk warning and disclaimer: The market has risks, and investment should be cautious. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial conditions, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article align with their specific circumstances. Investment based on this is at one's own risk
Novo Nordisk's sales in the first quarter were DKK 78.09 billion, estimated at DKK 78.7 billion.
Risk Warning and Disclaimer
The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article align with their specific circumstances. Investment based on this is at one's own risk